<!doctype html><html lang=en><head><meta charset=utf-8><meta name=HandheldFriendly content="True"><meta name=MobileOptimized content="320"><meta name=viewport content="width=device-width,initial-scale=1,maximum-scale=1"><meta name=referrer content="no-referrer"><meta name=description content="Artificial intelligence-backed health-tech startup Viz.ai announced a $100 million Series D funding round thatbringsits total valuation to $1.2 billion. Tiger Global and Insight Partners led the round, with participation from Scale Ventures, Kleiner Perkins, Threshold, GV, Sozo Ventures, CRV and Susa."><meta name=robots content="index,follow,noarchive"><link href="https://fonts.googleapis.com/css?family=Open+Sans:400|Old+Standard+TT:400&display=swap" rel=stylesheet media=print type=text/css onload='this.media="all"'><title>Stroke care coordination company Viz.ai lands $100M</title><link rel=canonical href=./stroke-care-coordination-company-viz-ai-lands-100m.html><style>*{border:0;font:inherit;font-size:100%;vertical-align:baseline;margin:0;padding:0;color:#000;text-decoration-skip:ink}body{font-family:open sans,myriad pro,Myriad,sans-serif;font-size:17px;line-height:160%;color:#1d1313;max-width:700px;margin:auto}p{margin:20px 0}a img{border:none}img{margin:10px auto;max-width:100%;display:block}.left-justify{float:left}.right-justify{float:right}pre,code{font:12px Consolas,liberation mono,Menlo,Courier,monospace;background-color:#f7f7f7}code{font-size:12px;padding:4px}pre{margin-top:0;margin-bottom:16px;word-wrap:normal;padding:16px;overflow:auto;font-size:85%;line-height:1.45}pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}pre code{display:inline;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}pre code::before,pre code::after{content:normal}em,q,em,dfn{font-style:italic}.sans,html .gist .gist-file .gist-meta{font-family:open sans,myriad pro,Myriad,sans-serif}.mono,pre,code,tt,p code,li code{font-family:Menlo,Monaco,andale mono,lucida console,courier new,monospace}.heading,.serif,h1,h2,h3{font-family:old standard tt,serif}strong{font-weight:600}q:before{content:"\201C"}q:after{content:"\201D"}del,s{text-decoration:line-through}blockquote{font-family:old standard tt,serif;text-align:center;padding:50px}blockquote p{display:inline-block;font-style:italic}blockquote:before,blockquote:after{font-family:old standard tt,serif;content:'\201C';font-size:35px;color:#403c3b}blockquote:after{content:'\201D'}hr{width:40%;height:1px;background:#403c3b;margin:25px auto}h1{font-size:35px}h2{font-size:28px}h3{font-size:22px;margin-top:18px}h1 a,h2 a,h3 a{text-decoration:none}h1,h2{margin-top:28px}#sub-header,.date{color:#403c3b;font-size:13px}#sub-header{margin:0 4px}#nav h1 a{font-size:35px;color:#1d1313;line-height:120%}.posts_listing a,#nav a{text-decoration:none}li{margin-left:20px}ul li{margin-left:5px}ul li{list-style-type:none}ul li:before{content:"\00BB \0020"}#nav ul li:before,.posts_listing li:before{content:'';margin-right:0}#content{text-align:left;width:100%;font-size:15px;padding:60px 0 80px}#content h1,#content h2{margin-bottom:5px}#content h2{font-size:25px}#content .entry-content{margin-top:15px}#content .date{margin-left:3px}#content h1{font-size:30px}.highlight{margin:10px 0}.posts_listing{margin:0 0 50px}.posts_listing li{margin:0 0 25px 15px}.posts_listing li a:hover,#nav a:hover{text-decoration:underline}#nav{text-align:center;position:static;margin-top:60px}#nav ul{display:table;margin:8px auto 0}#nav li{list-style-type:none;display:table-cell;font-size:15px;padding:0 20px}#links{display:flex;justify-content:space-between;margin:50px 0 0}#links :nth-child(1){margin-right:.5em}#links :nth-child(2){margin-left:.5em}#not-found{text-align:center}#not-found a{font-family:old standard tt,serif;font-size:200px;text-decoration:none;display:inline-block;padding-top:225px}@media(max-width:750px){body{padding-left:20px;padding-right:20px}#nav h1 a{font-size:28px}#nav li{font-size:13px;padding:0 15px}#content{margin-top:0;padding-top:50px;font-size:14px}#content h1{font-size:25px}#content h2{font-size:22px}.posts_listing li div{font-size:12px}}@media(max-width:400px){body{padding-left:20px;padding-right:20px}#nav h1 a{font-size:22px}#nav li{font-size:12px;padding:0 10px}#content{margin-top:0;padding-top:20px;font-size:12px}#content h1{font-size:20px}#content h2{font-size:18px}.posts_listing li div{font-size:12px}}@media(prefers-color-scheme:dark){*,#nav h1 a{color:#fdfdfd}body{background:#121212}pre,code{background-color:#262626}#sub-header,.date{color:#bababa}hr{background:#ebebeb}}</style></head><body><section id=nav><h1><a href=./index.html>JazzVib</a></h1><ul><li><a href=./index.xml>Rss</a></li><li><a href=./sitemap.xml>Sitemap</a></li></ul></section><section id=content><h1>Stroke care coordination company Viz.ai lands $100M</h1><div id=sub-header>June 2024 · 3 minute read</div><div class=entry-content><img src=https://cdn.statically.io/img/247newsaroundtheworld.com/wp-content/uploads/2022/04/mri_scans_of_the_human_brain_mobi-getty_wladimir_bulgar_compressed.jpg style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>Artificial intelligence-backed health-tech startup Viz.ai announced a $100 million Series D funding round that&nbsp;brings&nbsp;its total valuation to $1.2 billion. Tiger Global and Insight Partners led the round, with participation from Scale Ventures, Kleiner Perkins, Threshold, GV, Sozo Ventures, CRV and Susa.&nbsp;</span></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>This news comes roughly a year after the company closed its</span> $71 million Series C round. As of today, the company has more than $250 million in venture investment.&nbsp;</p><p dir=ltr><strong><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>WHAT IT DOES</span></strong></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>Viz.ai built a care-coordination tool designed to help clinical teams share images and detect potential diseases. The product’s AI tool is able to help triage the clinical images and detect strokes, and in turn help care teams prioritize patients. Currently its offering includes AI detection productions for aortic diseases, pulmonary embolism and cerebral aneurysms. The company noted that it has a pending 510(k) clearance for subdural hematoma.&nbsp;</span></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>Specialists using the system are able to access a mobile view of scans, which allows them to zoom in and out of images and visualize the scan in 3D.</span></p><p dir=ltr><strong><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>WHAT IT’S FOR&nbsp;</span></strong></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>The company said the new funds will help fuel growth in the company. The money will also go towards adding new disease-triaging capabilities to&nbsp;the Viz Platform.&nbsp;</span></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>“We will continue to invest heavily in cutting-edge technology and services to integrate deeply into the clinical workflow, allowing us to automate disease detection, increase diagnostic rates and enhance workflows across the entire hub and spoke health system,” Dr. Chris Mansi, Viz.ai cofounder and CEO, said in a statement.</span></p><p dir=ltr><span>“More patients receive the right treatment, resulting in better patient outcomes and improved financial efficiency for the health system.”</span></p><p><strong><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>MARKET SNAPSHOT&nbsp;</span></strong></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>Founded in 2016, the company landed an </span>FDA De Novo in 2018 for its Viz.ai Contact, a clinical decision-support tool that analyzes CT scans and flags a detected stroke. The startup has continued to work with the FDA on new algorithms. Most recently, in February the company landed an FDA 510(k) clearance for its algorithm designed to detect cerebral aneurysms.&nbsp;</p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>There are several digital health companies working in the stroke-care space. For example, in 2021 Indian startup </span>Qure.ai announced a new stroke management platform that lets providers remotely diagnose and make decisions. Additionally, stroke-triaging company MindRhythm launched a multicenter clinical trial to test the effectiveness of its stroke-detecting technology also in 2021.&nbsp;</p><p dir=ltr><strong><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>ON THE RECORD&nbsp;</span></strong></p><p dir=ltr><span id=docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060>“Viz.ai is the standout AI healthcare company; they are first-in-class in intelligent care coordination, with a solid foundation of clinical evidence supporting the value delivered to healthcare providers and patients,”&nbsp;John Curtius, partner at Tiger Global, said in a statement. “We see meaningful upside as the company expands to help life science companies expedite clinical trials and accelerate patient access to new effective treatments.”</span></p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmhqZGy7psPSmqmorZ6Zwamx1qippZxemLyue8eemKWsmGK7psPSaKqtqp%2Bgsm6vwKucZpufpL%2Bltc2aq6KnnmKwsLnPmqWyZaaex26tyGajmqaUqHpyfI%2BmZg%3D%3D</p></div><div id=links><a href=./ancient-roman-gold-coins.html>&#171;&nbsp;Ancient Roman Gold Coins Believed To Be Worth Millions Unearthed</a>
<a href=./michael-b-jordan-2.html>Michael B. Jordan Age, Net Worth, Girlfriend, Family and Biography (Updated 2023)&nbsp;&#187;</a></div></section><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/floating.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>